Why is Aurobindo Pharma falling/rising?

As of 15-Jul, Aurobindo Pharma Ltd. is experiencing a price increase, currently at 1,154.00, reflecting a rise of 16.3 or 1.43%. The stock has been gaining for the last two days, with a total return of 2.63% during this period. However, it opened with a loss of 2.87% today and touched an intraday low of Rs 1105.05. Despite this, the stock is trading above its 5-day, 20-day, and 100-day moving averages, although it remains below its 50-day and 200-day moving averages. The stock has shown a decline of 16.00% over the past year, but its profits have increased by 5.3%, indicating a potential for recovery. The company has a low Debt to Equity ratio and an attractive valuation, which may contribute positively to investor sentiment.
In the broader market context, Aurobindo Pharma's short-term performance of +0.94% over the past week contrasts with the Sensex, which has declined by 1.36%. This suggests that the stock is performing relatively well compared to the overall market. Additionally, high institutional holdings at 41.57% indicate strong investor confidence, as these investors typically have better resources to analyze company fundamentals. However, the falling delivery volume, which has decreased by 18.04% against the 5-day average, may signal a lack of retail investor interest, potentially impacting future price movements.